Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 USD | -1.41% |
|
-2.52% | -1.76% |
May. 15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
May. 15 | Aytu BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.76% | 16.66M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Earnings Flash (AYTU) AYTU BIOPHARMA Posts Q1 Revenue $27.7M, vs. Street Est of $24.3M